Literature DB >> 7871093

Effects of disrupting the cholinergic system on short-term spatial memory in rats.

J S Andrews1, J H Jansen, S Linders, A Princen.   

Abstract

The effects of disrupting the muscarinic or nicotinic systems on short-term spatial memory were investigated using a delayed matching to position (DMTP) procedure. Rats were trained on the DMTP until stability and then divided into two groups: one group was implanted with an indwelling cannula aimed at the lateral ventricle. The cannulated group received injections of selective muscarinic antagonists (pirenzepine, M1; AFDX 116, M2; UH-AH 37, M1/M3) or hemicholinium-3 (a choline uptake inhibitor). The remaining animals were treated with conventional muscarinic antagonists (scopolamine, methyl scopolamine) or nicotinic channel blockers (mecamylamine, hexamethonium). Scopolamine, methyl scopolamine and UH-AH 37 disrupted all performance parameters in a non-specific but dose related manner. Pirenzepine disrupted accuracy in a delay, but not dose dependent manner, and exerted no other negative effects on performance. Hemicholinium-3-induced performance deficits showed some elements of effects seen following pirenzepine and scopolamine (delay dependent effects on accuracy, some negative effects on other motoric aspects of performance). AFDX 116 and hexamethonium had no significant effects on performance with respect to control. Mecamylamine reduced accuracy and increased response latencies at the highest dose tested. These data indicate that muscarinic antagonists are more effective at disrupting mnemonic performance than nicotinic blockers, and moreover, that distinct muscarinic receptors may have differential effects on cognitive performance.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7871093     DOI: 10.1007/bf02245572

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  41 in total

1.  Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats.

Authors:  S B Dunnett
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 2.  Alzheimer's disease: a disorder of cortical cholinergic innervation.

Authors:  J T Coyle; D L Price; M R DeLong
Journal:  Science       Date:  1983-03-11       Impact factor: 47.728

3.  Determination of muscarinic agonist potencies at M1 and M2 muscarinic receptors in a modified pithed rat preparation.

Authors:  P Angeli; L Brasili; F Cantalamessa; G Marucci; J Wess
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-12       Impact factor: 3.000

4.  Role of prefrontal cortex and striatal output systems in short-term memory deficits associated with ageing, basal forebrain lesions, and cholinergic-rich grafts.

Authors:  S B Dunnett
Journal:  Can J Psychol       Date:  1990-06

5.  Evidence for a preferential involvement of M1 muscarinic receptors in representational memory.

Authors:  W S Messer; M Bohnett; J Stibbe
Journal:  Neurosci Lett       Date:  1990-08-14       Impact factor: 3.046

6.  Scopolamine differentially disrupts the behavior of male and female Wistar rats in a delayed nonmatching to position procedure.

Authors:  A van Hest; J Stroet; F van Haaren; M Feenstra
Journal:  Pharmacol Biochem Behav       Date:  1990-04       Impact factor: 3.533

7.  Effects of Nucleus Basalis Magnocellularis Lesions in Rats on Delayed Matching and Non-Matching to Position Tasks.

Authors:  Stephen B. Dunnett; Derek C. Rogers; Graham H. Jones
Journal:  Eur J Neurosci       Date:  1989-07       Impact factor: 3.386

Review 8.  The design of novel muscarinic partial agonists that have functional selectivity in pharmacological preparations in vitro and reduced side-effect profile in vivo.

Authors:  S B Freedman; G R Dawson; L L Iversen; R Baker; R J Hargreaves
Journal:  Life Sci       Date:  1993       Impact factor: 5.037

9.  The effects of scopolamine and methylscopolamine on visual and auditory discriminations in male and female Wistar rats.

Authors:  F van Haaren; A van Hest
Journal:  Pharmacol Biochem Behav       Date:  1989-03       Impact factor: 3.533

10.  Hemicholinium-3 impairs spatial learning and the deficit is reversed by cholinomimetics.

Authors:  J J Hagan; J H Jansen; C L Broekkamp
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

View more
  10 in total

1.  Effects of the selective M1 muscarinic receptor antagonist dicyclomine on emotional memory.

Authors:  R V Fornari; K M Moreira; M G Oliveira
Journal:  Learn Mem       Date:  2000 Sep-Oct       Impact factor: 2.460

2.  Carbachol-induced long-term synaptic depression is enhanced during senescence at hippocampal CA3-CA1 synapses.

Authors:  Ashok Kumar
Journal:  J Neurophysiol       Date:  2010-05-26       Impact factor: 2.714

3.  Type and severity of cognitive decline in older adults after noncardiac surgery.

Authors:  Catherine C Price; Cynthia W Garvan; Terri G Monk
Journal:  Anesthesiology       Date:  2008-01       Impact factor: 7.892

Review 4.  Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.

Authors:  P A Newhouse; A Potter; E D Levin
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

5.  A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment.

Authors:  Inge Klinkenberg; Arjan Blokland
Journal:  Psychopharmacology (Berl)       Date:  2011-02-19       Impact factor: 4.530

Review 6.  Exploring the multifactorial nature of autism through computational systems biology: calcium and the Rho GTPase RAC1 under the spotlight.

Authors:  Fares Zeidán-Chuliá; José Luiz Rybarczyk-Filho; Alla B Salmina; Ben-Hur Neves de Oliveira; Mami Noda; José Cláudio F Moreira
Journal:  Neuromolecular Med       Date:  2013-03-02       Impact factor: 3.843

7.  Cholinergic profiles in the Goettingen miniature pig (Sus scrofa domesticus) brain.

Authors:  Laura J Mahady; Sylvia E Perez; Dwaine F Emerich; Lars U Wahlberg; Elliott J Mufson
Journal:  J Comp Neurol       Date:  2016-08-30       Impact factor: 3.215

8.  Dose-specific effects of scopolamine on canine cognition: impairment of visuospatial memory, but not visuospatial discrimination.

Authors:  J A Araujo; A D F Chan; L L Winka; P A Seymour; N W Milgram
Journal:  Psychopharmacology (Berl)       Date:  2004-03-17       Impact factor: 4.530

9.  Vascular action as the primary mechanism of cognitive effects of cholinergic, CNS-acting drugs, a rat phMRI BOLD study.

Authors:  Pál Kocsis; István Gyertyán; János Éles; Judit Laszy; Nikolett Hegedűs; Dávid Gajári; Levente Deli; Zsófia Pozsgay; Szabolcs Dávid; Károly Tihanyi
Journal:  J Cereb Blood Flow Metab       Date:  2014-03-19       Impact factor: 6.200

Review 10.  Cellular, molecular, and genetic substrates underlying the impact of nicotine on learning.

Authors:  Thomas J Gould; Prescott T Leach
Journal:  Neurobiol Learn Mem       Date:  2013-08-22       Impact factor: 2.877

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.